Becton Dickinson and Company (NYSE:BDX) Analyst Rating Consensus

Becton Dickinson and Company (NYSE:BDX) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.71 by 14 Brokerage Firm. 9 Wall Street Firms have rated the stock as a strong buys. 5 Brokerage Firms have advised hold.

Becton Dickinson and Company (NYSE:BDX): 11 Analyst have given the stock of Becton Dickinson and Company (NYSE:BDX) a near short term price target of $179.55. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $6.79. The higher price target estimate is at $190 while the lower price estimates are fixed at $169.

Becton Dickinson and Company (NYSE:BDX) rose 1.18% or 1.99 points on Tuesday and made its way into the gainers of the day. After trading began at $168.55 the stock was seen hitting $170.68 as a peak level and $168.55 as the lowest level. The stock ended up at $170.02. The daily volume was measured at 1,368,310 shares. The 52-week high of the share price is $171.64 and the 52-week low is $128.87. The company has a market cap of $36,079 million.

Shares of Becton, Dickinson and Company rose by 0.6% in the last five trading days and 3.44% for the last 4 weeks. Becton, Dickinson and Company is up 14.13% in the last 3-month period. Year-to-Date the stock performance stands at 11.26%.

Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.